Den europeiske union -
litauisk -
EMA (European Medicines Agency)
supemtek
sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - gripas, žmogus - vakcinos - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.
Den europeiske union -
litauisk -
EMA (European Medicines Agency)
xofluza
roche registration gmbh - baloxavir marboxil - gripas, žmogus - antivirusiniai vaistai sisteminiam naudojimui - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.
Den europeiske union -
litauisk -
EMA (European Medicines Agency)
skysona
bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - kiti nervų sistemos vaistai - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.
Litauen -
litauisk -
SMCA (Valstybinė vaistų kontrolės tarnyba)
macrogol 4000 recordati
casen recordati s.l. - makrogolis 4000 - milteliai geriamajam tirpalui paketėlyje - 4 g - macrogol
Litauen -
litauisk -
SMCA (Valstybinė vaistų kontrolės tarnyba)
macrogol 4000 casen recordati
casen recordati s.l. - makrogolis 4000 - milteliai geriamajam tirpalui paketėlyje - 10 g - macrogol
Den europeiske union -
litauisk -
EMA (European Medicines Agency)
arexvy
glaxosmithkline biologicals s.a. - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiraciniu sincitijaus infekcijos - vakcinos - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. naudoti šios vakcinos turėtų būti laikantis oficialių rekomendacijų.